These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 16908270

  • 21. Reversal of acute cellular rejection after renal transplantation with Campath-1H.
    Basu A, Ramkumar M, Tan HP, Khan A, McCauley J, Marcos A, Fung JJ, Starzl TE, Shapiro R.
    Transplant Proc; 2005 Mar; 37(2):923-6. PubMed ID: 15848576
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Alemtuzumab induction and antibody-mediated kidney rejection after simultaneous pancreas-kidney transplantation.
    Pascual J, Pirsch JD, Odorico JS, Torrealba JR, Djamali A, Becker YT, Voss B, Leverson GE, Knechtle SJ, Sollinger HW, Samaniego-Picota MD.
    Transplantation; 2009 Jan 15; 87(1):125-32. PubMed ID: 19136902
    [Abstract] [Full Text] [Related]

  • 27. Alemtuzumab induction with tacrolimus monotherapy in de novo renal transplantation.
    Villanueva ME, Muñoz AS, Casasola CC, Africa JB, Danguilan RA, Ona ET.
    Transplant Proc; 2008 Sep 15; 40(7):2222-5. PubMed ID: 18790198
    [Abstract] [Full Text] [Related]

  • 28. C4d positivity is often associated with acute cellular rejection in renal transplant biopsies following Campath-1H (Alemtuzumab) induction.
    Zhang PL, Malek SK, Blasick TM, Pennington JR, Masker KK, Lun M, Potdar S.
    Ann Clin Lab Sci; 2007 Sep 15; 37(2):121-6. PubMed ID: 17522366
    [Abstract] [Full Text] [Related]

  • 29. The evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantation.
    Magliocca JF, Knechtle SJ.
    Transpl Int; 2006 Sep 15; 19(9):705-14. PubMed ID: 16918530
    [Abstract] [Full Text] [Related]

  • 30. Alemtuzumab (Campath-1H) induction in a pediatric heart transplant: successful outcome and rationale for its use.
    Das B, Shoemaker L, Recto M, Austin E, Dowling R.
    J Heart Lung Transplant; 2008 Feb 15; 27(2):242-4. PubMed ID: 18267235
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Preliminary experience with Campath 1H induction combined with low-dose monotherapy of tacrolimus in small bowel transplantation].
    Li YX, Li N, Ni XD, Li YS, Li M, Shen J, Li JS.
    Zhonghua Wai Ke Za Zhi; 2009 Jun 01; 47(11):810-3. PubMed ID: 19961008
    [Abstract] [Full Text] [Related]

  • 34. Alemtuzumab induction in kidney transplantation: clinical results and impact on T-regulatory cells.
    Morales J, Bono MR, Fierro A, Iñiguez R, Zehnder C, Rosemblatt M, Calabran L, Herzog C, Benavente D, Aguiló J, Pefaur J, Alba A, Ferrario M, Simon W, Contreras L, Buckel E.
    Transplant Proc; 2008 Nov 01; 40(9):3223-8. PubMed ID: 19010240
    [Abstract] [Full Text] [Related]

  • 35. Induction therapy for adult small bowel transplant with Campath-1H.
    Nishida S, Levi D, Kato T, Madariaga J, Nery J, Tzakis A.
    Transplant Proc; 2002 Aug 01; 34(5):1889-91. PubMed ID: 12176616
    [No Abstract] [Full Text] [Related]

  • 36. Use of alemtuzumab (Campath-1H) as induction therapy in pediatric kidney transplantation.
    Ona ET, Danguilan RA, Africa J, Cabanayan-Casasola CB, Antonio ZL, Gutierrez-Marbella MA, dela Cruz R, Bumanglag N, Espedilla ME.
    Transplant Proc; 2008 Sep 01; 40(7):2226-9. PubMed ID: 18790199
    [Abstract] [Full Text] [Related]

  • 37. Alemtuzumab induction in deceased donor kidney transplantation.
    Shin M, Song SH, Kim JM, Kwon CH, Joh JW, Lee SK, Kim SJ.
    Transplant Proc; 2011 Sep 01; 43(6):2365-78. PubMed ID: 21839271
    [Abstract] [Full Text] [Related]

  • 38. Pediatric living donor kidney transplantation under alemtuzumab pretreatment and tacrolimus monotherapy: 4-year experience.
    Tan HP, Donaldson J, Ellis D, Moritz ML, Basu A, Morgan C, Vats AN, Erkan E, Shapiro R.
    Transplantation; 2008 Dec 27; 86(12):1725-31. PubMed ID: 19104412
    [Abstract] [Full Text] [Related]

  • 39. Subcutaneous administration of alemtuzumab in simultaneous pancreas-kidney transplantation.
    Clatworthy MR, Sivaprakasam R, Butler AJ, Watson CJ.
    Transplantation; 2007 Dec 27; 84(12):1563-7. PubMed ID: 18165765
    [Abstract] [Full Text] [Related]

  • 40. Efficacy and safety of induction therapy with alemtuzumab in kidney transplantation: a meta-analysis.
    Shou ZF, Zhou Q, Cai JR, Cheng J, He Q, Wu JY, Chen JH.
    Chin Med J (Engl); 2009 Jul 20; 122(14):1692-8. PubMed ID: 19719973
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.